Art Unit 1674
Group 1670Virology and Related Immunology
- Active examiners
- 27
- Average office actions per grant
- 1.92
Grant ratio
- Art Unit 1674
- 54.7%
- Group 1670
- 57.9%
Active examiners
| Kimberly Chong | 73.1% | 1.78 | August 2026 |
|---|---|---|---|
| Amy Bowman | 81.6% | 1.64 | August 2026 |
| Jane Zara | 74.0% | 1.89 | August 2026 |
| Dana Shin | 30.5% | 2.84 | August 2026 |
| Brian Whiteman | 68.6% | 1.89 | August 2026 |
| Terra C. Gibbs | 72.2% | 1.77 | August 2026 |
| J. E. Angell | 67.4% | 1.86 | August 2026 |
| Ekaterina Poliakova | 60.5% | 2.19 | August 2026 |
| Sean Mcgarry | 73.4% | 1.52 | June 2026 |
| Tracy Vivlemore | 74.4% | 1.58 | August 2026 |
| Zachary C Howard | 24.4% | 1.90 | August 2026 |
| Claire Kaufman | 18.2% | 1.82 | August 2026 |
| Andrea Mccollum | 18.5% | 2.19 | August 2026 |
| Sandra Dillahunt | 16.7% | 2.68 | August 2026 |
| Gyan Chandra | 22.4% | 1.76 | August 2026 |
| Ruixiang Li | 25.3% | 1.94 | August 2026 |
| Danaya L Middleton | 8.6% | 1.87 | August 2026 |
| Prema Mertz | 19.2% | 1.76 | August 2026 |
| Michael Pak | 20.0% | 2.37 | August 2026 |
| Examiner Dong Jiang | 11.9% | 2.18 | June 2026 |
| Xiaozhen Xie | 22.2% | 2.37 | August 2026 |
| Vanessa L. Ford | 0.0% | 2.10 | August 2026 |
| Syed J Abbas | 0.0% | N/A | August 2026 |
| Brandon R Schwechter | 0.0% | N/A | August 2026 |
| Tian Yang | 0.0% | N/A | July 2026 |
| Christopher M. Babic | 100.0% | 2.06 | August 2026 |
| Julia A Rossi | 100.0% | 1.00 | August 2026 |
Examiner distribution
- Median grant ratio
- 24.4%
- Middle 50% of grant ratios
- 18.4%–70.4%
- Median office actions / grant
- 1.89
- Middle 50% of office actions / grant
- 1.77–2.19
Active examiners with at least 20 applications.
Other associated examiners
Examiners without recent activity.
| Richard Schnizer | 55.8% | 2.36 | May 2025 Appears inactive |
|---|---|---|---|
| Jennifer Pitrak Mcdonald | 51.7% | 2.78 | November 2020 Appears inactive |
| Elizabeth C. Kemmerer | 26.1% | 1.97 | October 2025 Appears inactive |
| Leslie Andrea Greene | 66.7% | 1.00 | December 2024 Appears inactive |
Based on available public USPTO records; may be incomplete.